SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 114 filers reported holding SAGENT PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $573,000 | +58.7% | 38,230 | +29.0% | 0.00% | – |
| Q1 2016 | $361,000 | -31.8% | 29,630 | -10.8% | 0.00% | – |
| Q4 2015 | $529,000 | -3.6% | 33,230 | -7.3% | 0.00% | – |
| Q3 2015 | $549,000 | -37.1% | 35,830 | -0.2% | 0.00% | -100.0% |
| Q2 2015 | $873,000 | +16.2% | 35,900 | +11.1% | 0.00% | 0.0% |
| Q1 2015 | $751,000 | -14.1% | 32,300 | -7.2% | 0.00% | 0.0% |
| Q4 2014 | $874,000 | -19.2% | 34,800 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $1,082,000 | +34.9% | 34,800 | +12.3% | 0.00% | 0.0% |
| Q2 2014 | $802,000 | +32.6% | 31,000 | +19.7% | 0.00% | 0.0% |
| Q1 2014 | $605,000 | -16.1% | 25,900 | -8.8% | 0.00% | 0.0% |
| Q4 2013 | $721,000 | +57.4% | 28,400 | +26.5% | 0.00% | – |
| Q3 2013 | $458,000 | -7.5% | 22,457 | -4.7% | 0.00% | -100.0% |
| Q2 2013 | $495,000 | – | 23,572 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 6,495,416 | $97,301,000 | 26.57% |
| Stonepine Capital Management, LLC | 356,307 | $5,337,000 | 5.47% |
| Penn Capital Management Company, LLC | 1,841,035 | $27,673,000 | 1.57% |
| SECTORAL ASSET MANAGEMENT INC | 1,008,265 | $15,104,000 | 1.56% |
| Tamarack Advisers, LP | 259,336 | $3,885,000 | 1.49% |
| THB ASSET MANAGEMENT | 632,499 | $9,474,000 | 1.23% |
| JW Asset Management, LLC | 101,630 | $1,522,000 | 1.21% |
| Healthcare Value Capital, LLC | 50,000 | $749,000 | 0.91% |
| Kerrisdale Advisers, LLC | 190,372 | $2,851,000 | 0.77% |
| Healthcare Value Capital, LLC | 35,000 | $524,000 | 0.64% |